Role of hippocampal-CaMKII in serotonin 5-HTIA receptor-mediated learning deficit in rats

Neuropsychopharmacology

Volumn 29, Issue 12, 2004, Pages 2216-2224

  Moyano, Sonia ^a   Del Río, Joaquín ^a   Frechilla, Diana ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

5 HTIA receptors; CaMKII; Hippocampus; Kinase; Memory; Phosphatase

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; LEARNING DISORDER; LONG TERM MEMORY; MALE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SHOCK; TASK PERFORMANCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CARRIER PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG INTERACTIONS; HIPPOCAMPUS; LEARNING DISORDERS; MALE; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS;

EID: 9644266686     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300504     Document Type: Article

References (56)

1. Allen PB, Hvalby O, Jensen V, Errington ML, Ramsay M, Chaudhry FA et al (2000). Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms. J Neurosci 20: 3537-3543.
2. 3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology 117: 137-148.
3. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR (1997). Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276: 2042-2045.
4. Bayer K-U, Koninck PD, Leonard AS, Hell JW, Schulman H (2001). Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411: 801-805.
5. Bliss TV, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
6. Blitzer RD, Connor JH, Brown GP, Wong T, Shenolikar S, Iyengar R et al (1998). Gating of CaMKII by c-AMP-regulated protein phosphatase activity during LTP. Science 280: 1940-1942.
7. Boast C, Bartolomeo AA, Morris H, Moyer JA (1999). 5-HT antagonists attenuate MK801-impaired radial arm maze performance in rats. Neurobiol Learn Mem 71: 259-271.
8. Buhot M-C (1997). Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7: 243-254.
9. 2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. J Biol Chem 277: 36553-36562.
10. Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K et al (2000). Dopamine and cAMP-regulated phosphoprotein 32kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J Neurosci 20: 8443-8451.
11. 2+/calmodulin-dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity. Eur J Neurosci 10: 2669-2676.
12. 1A receptors. Br J Pharmacol 105: 720-726.
13. 1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors. Neuropharmacology 38: 1165-1173.
14. 1A receptor agonist, impairs performance in a passive avoidance task. Eur J Pharmacol 211: 227-234.
15. 1A receptor subtype. Quart J Exp Psychol B 53: 225-238.
16. Corradetti R, Ballerini L, Pugliese AM, Pepeu G (1992). Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience 46: 511-518.
17. Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB et al (2000). Alterations in subunit expression, composition and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57: 342-352.
18. 1A receptor-mediated inhibition of long-term potentiation in rat visual cortex. Eur J Pharmacol 349: 221-224.
19. 1A receptor selectively suppresses NMDA receptor-mediated synaptic excitation in the rat visual cortex. Brain Res 827: 225-228.
20. Elgersma Y, Silva AJ (1999). Molecular mechanisms of synaptic plasticity and memory. Curr Opin Neurobiol 9: 209-213.
21. Endo S, Zhou X, Connor J, Wang B, Shenolikar S (1996). Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 35: 5220-5228.
22. Fink CC, Meyer T (2002). Molecular mechanisms of CaMKII activation in neuronal plasticity. Curr Opin Neurobiol 12: 293-299.
23. Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM (2002). Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418: 970-975.
24. Gustafson EL, Girault JA, Hemmings Jr HC, Nairn AC, Greengard P (1991). Immunocytochemical localization of phosphatase inhibitor-1 in rat brain. J Comp Neurol 310: 170-188.
25. Heyser CJ, Fienberg AA, Greengard P, Gold LH (2000). DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res 867: 122-130.
26. 2+/calmodulin- dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71: 473-510.
27. Izquierdo I, Medina JH (1997). Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain regions. Neurobiol Learn Mem 68: 285-316.
28. Izquierdo I, Schröder N, Netto CA, Medina JH (1999). Novelty causes time-dependent retrograde amnesia for one-trial avoidance in rats through NMDA receptor- and CaMKII-dependent mechanisms in the hippocampus. Eur J Neurosci 11: 3323-3328.
29. Kant GJ, Wylie RM, Chu K, Ghosh S (1998). Effects of the serotonin agonists 8-OH-DPAT, buspirone, and DOI on water maze performance. Pharmacol Biochem Behav 59: 729-735.
30. Kennedy MB (1997). The postsynaptic density at glutamatergic synapses. Trends Neurosci 20: 264-268.
31. 1A receptors in the rat brain. J Neurosci Res 46: 697-708.
32. Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995). Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737-1740.
33. Leonard AS, Lim IA, Hemsworth DE, Horne MC, Hell JW (1999). Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 96: 3239-3244.
34. 1A receptors. Eur J Neurosci 11: 1491-1500.
35. 2+/CaM-responsive pool of CaMKII by scaffold-dependent autophosphorylation. Neuron 40: 1185-1197.
36. Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia P (1997). Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 760: 68-73.
37. 1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism. Eur J Pharmacol 236: 177-182.
38. Milner B, Squire LR, Kandel ER (1998). Cognitive neuroscience and the study of memory. Neuron 20: 445-468.
39. 1A receptor involvement in passive avoidance in the rat. Br J Pharmacol 125: 499-509.
40. Misane I, Ögren SO (2000). Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22: 168-190.
41. O'Brien RJ, Lau L-F, Huganir RL (1998). Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr Opin Neurobiol 8: 364-369.
42. 1A receptors. Br J Pharmacol 128: 1691-1698.
43. Ouimet CC, Miller PE, Hemmings HC, Walaas SI, Greengard P (1984). DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4: 111-124.
44. Pazos A, Palacios JM (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205-230.
45. Riedel G, Platt B, Micheau J (2003). Glutamate receptor function in learning and memory. Behav Brain Res 140: 1-47.
46. Santucci AC, Shaw C (2003). Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats. Neurobiol Learn Mem 79: 136-141.
47. 1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease. Curr Pharmac Design 8: 139-145.
48. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol 95: 975-985.
49. Shen K, Meyer T (1999). Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 284: 162-166.
50. Shi SH, Hayashi Y, Esteban JA, Malinow R (2001). Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105: 331-334.
51. Shobe J (2002). The role of PKA, CaMKII, and PKC in avoidance conditioning: permissive or instructive? Neurobiol Learn Mem 77: 291-312.
52. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem 58: 2119-2128.
53. 2+/calmodulin-dependent protein kinase II into postsynaptic density after decapitation. J Neurochem 63: 1529-1537.
54. Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P (2002). DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci USA 99: 3188-3193.
55. Yasuno F, Suhara T, Nakayama T, Ichimiya T, Okubo Y, Takano A et al (2003). Inhibitory effect of hippocampal 5-HT(1A) receptors on human explicit memory. Am J Psychiatry 160: 334-340.
56. 2+/calmodulin-dependent kinase II from postsynaptic densities. FEBS Lett 446: 239-242.